Hanmi Pharmaceutical Co. said Wednesday that it will launch a combination drug Naxozol, which combines the two most commonly prescribed naproxen, a non-steroidal anti-inflammatory agent (NSAID) and esomeprazole strontium in one tablet, from next month.
Naproxen is often effective in combating arthritis pain. However, they have many potential risks, especially if used for a long time. They sh...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.